Interparfums Q3 Sales Rise-May 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Interparfums Q3 Sales Rise

Oct 20, 2025 1:45 PM

04:28 PM EDT, 10/20/2025 (MT Newswires) -- Interparfums (IPAR) reported Q3 net sales late Monday of $430 million, up from $425 million a year ago.

Three analysts polled by FactSet expected $431.8 million.

European net sales increased to $295 million from $282 million a year earlier, while US net sales declined to $137 million from $146 million a year earlier.

Previous page： KULR Technology Expands Bitcoin Holdings With Additional $10 Million Purchase Next page： Market Chatter: Goldman Sachs May Selectively Pursue Asset, Wealth Management Acquisitions, CEO Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

KULR Technology Expands Bitcoin Holdings With Additional $10 Million Purchase

Feb 11, 2025

10:46 AM EST, 02/11/2025 (MT Newswires) -- KULR Technology Group ( KULR ) said Tuesday it grew its bitcoin purchases for its bitcoin treasury by a further $10 million to reach a total of about $60 million in such acquisitions. The company said it made the additional purchases at a weighted average price of $103,905 per bitcoin, adding that it...

Market Chatter: Goldman Sachs May Selectively Pursue Asset, Wealth Management Acquisitions, CEO Says

Feb 11, 2025

10:55 AM EST, 02/11/2025 (MT Newswires) -- Goldman Sachs ( GS ) is open to acquisitions in asset and wealth management, but would be selective in its approach to any potential deals, Chief Executive David Solomon said Tuesday, according to Reuters. Solomon told a UBS financial services conference in Miami that the bank would consider things that could accelerate our...

Update: Travere Therapeutics Completes US FDA Meeting Ahead of Potential Kidney Disease Drug Submission; Shares Rise Over 13%

Feb 11, 2025

10:59 AM EST, 02/11/2025 (MT Newswires) -- (Updates with recent share movement in the headline and first paragraph.) Travere Therapeutics ( TVTX ) shares were up over 13% in recent Tuesday trading after the company said it has completed a meeting with the US Food and Drug Administration and plans to submit a supplemental new drug application for approval of...

Update: QXO Stepping Up Efforts to Win Over Beacon Roofing Supply Shareholders to Buyout

Feb 11, 2025

10:56 AM EST, 02/11/2025 (MT Newswires) -- (Updates with QXO's comments in seventh, eighth and ninth paragraphs.) QXO (QXO) on Monday continued its push to persuade Beacon Roofing Supply ( BECN ) shareholders to accept its $124.25-per-share buyout offer, arguing that Beacon's board is misrepresenting aspects of the deal and undervaluing the proposal. Last week, Beacon's board reiterated its recommendation...